GMab-1, a high-affinity anti-3'-isoLM1/3',6'-isoLD1 IgG monoclonal antibody, raised in lacto-series ganglioside-defective knockout mice

Biochem Biophys Res Commun. 2010 Jan 1;391(1):750-5. doi: 10.1016/j.bbrc.2009.11.132. Epub 2009 Nov 26.

Abstract

The lacto-series gangliosides 3'-isoLM1 and 3',6'-isoLD1 have been identified as tumor-associated antigens whose formation is initiated by the Lc3-synthase. Until now, high-affinity IgG monoclonal antibodies (mAbs) against 3'-isoLM1 and 3',6'-isoLD1, which are highly expressed in gliomas, have not been developed, although mAbs against lacto-series gangliosides are powerful tools for functional studies. We previously produced the Lc3-synthase gene beta3Gn-T5 knockout mice. In this study, we immunized beta3Gn-T5 knockout mice with 3'-isoLM1/3',6'-isoLD1 and produced the anti-3'-isoLM1/3',6'-isoLD1 mAb GMab-1, of the IgG(3) subclass, which should be useful for functional analysis of lacto-series gangliosides and for antibody-based therapy of gliomas.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / biosynthesis
  • Antibodies, Monoclonal / immunology*
  • Biomarkers, Tumor / immunology*
  • Gangliosides / immunology*
  • Glioma / immunology*
  • Immunoglobulin G / biosynthesis
  • Immunoglobulin G / immunology*
  • Mice
  • Mice, Knockout
  • N-Acetylglucosaminyltransferases / genetics

Substances

  • Antibodies, Monoclonal
  • Biomarkers, Tumor
  • Gangliosides
  • Immunoglobulin G
  • IV(3)-NeuAc-LcOse4Cer
  • IV(3)-NeuAc-III(6)-NeuAc-LcOse4Cer
  • N-Acetylglucosaminyltransferases
  • lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase

Grants and funding